Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMUGENE LIMITED Major Shareholding Notification 2013

Dec 23, 2013

65124_rns_2013-12-23_18ac448c-4b13-4c09-bd74-a224cada1806.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Form 603

Corporations Act 2001 Section 671B

Notice of initial substantial holder

To Company Name/Scheme IMUGENE LIMITED ACN/ARSN 009 179 551 1. Details of substantial holder (1) Name Paul Hopper ACN/ARSN (if applicable) The holder became a substantial holder on 20/12 /13

2. Details of voting power

The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate (2) had a relevant interest (3) in on the date the substantial holder became a substantial holder are as follows:

Class of securities (4) Number of securities Person’s votes (5) Voting power (6)
Ordinary Fully Paid Shares (OFP)(escrowed until 20 December2014) 68,296,875 68,296,875 7.22%

3. Details of relevant interests

The nature of the relevant interest the substantial holder or an associate had in the following voting securities on the date the substantial holder became a substantial holder are as follows:

Holder of relevant interest Nature of relevant interest (7) Class and number of securities
Paul Hopper Indirect 68,296,875 OFP

4. Details of present registered holders

The persons registered as holders of the securities referred to in paragraph 3 above are as follows:

Holder of relevantinterest Registered holder ofsecurities Person entitled to beregistered as holder (8) Class and numberof securities
Paul Hopper KilinwataInvestmentsPtyLtd KilinwataInvestmentsPtyLtd 26,953,125,OFP
Paul Hopper Ms Deborah Anne Coleman Ms Deborah Anne Coleman 13,781,250 OFP
Paul Hopper Moreglade Pty Ltd Moreglade Pty Ltd 27,562,500 OFP

5. Consideration

The consideration paid for each relevant interest referred to in paragraph 3 above, and acquired in the four months prior to the day that the substantial holder became a substantial holder is as follows:

Holder of relevant interest Date of acquisition Consideration (9) Consideration (9) Class and number ofsecurities
Cash Non-Cash
Paul Hopper 20/12/13 Acquisition of Biolife Science QLDLimited 68,296,875 OFP

ASIC 603 PH 24 Dec 13.docx

Name and ACN/ARSN(if applinHe) Natwe of assochtbn
ParlHopper Indirect rdwad irierest ln shares held by:
Kllinwab InvesfrnenbPty Ltd
Ms Deborah Anne Coleman
liloreqlade PtY Ltd

Narne Address
140 S.BURLINGAMEAVENUE , LOS ANGELESCA 90049 , UNITED
Paul Hopper STATES